180 related articles for article (PubMed ID: 34416020)
1. Assessing and Interpreting Real-World Evidence Studies: Introductory Points for New Reviewers.
Wang SV; Schneeweiss S
Clin Pharmacol Ther; 2022 Jan; 111(1):145-149. PubMed ID: 34416020
[TBL] [Abstract][Full Text] [Related]
2. Use of real-world evidence for oncology clinical decision making in emerging economies.
Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
[TBL] [Abstract][Full Text] [Related]
3. Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.
Franklin JM; Pawar A; Martin D; Glynn RJ; Levenson M; Temple R; Schneeweiss S
Clin Pharmacol Ther; 2020 Apr; 107(4):817-826. PubMed ID: 31541454
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making.
Franklin JM; Glynn RJ; Martin D; Schneeweiss S
Clin Pharmacol Ther; 2019 Apr; 105(4):867-877. PubMed ID: 30636285
[TBL] [Abstract][Full Text] [Related]
5. Marketing Authorization Applications Made to the European Medicines Agency in 2018-2019: What was the Contribution of Real-World Evidence?
Flynn R; Plueschke K; Quinten C; Strassmann V; Duijnhoven RG; Gordillo-Marañon M; Rueckbeil M; Cohet C; Kurz X
Clin Pharmacol Ther; 2022 Jan; 111(1):90-97. PubMed ID: 34689339
[TBL] [Abstract][Full Text] [Related]
6. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB
Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318
[TBL] [Abstract][Full Text] [Related]
7. Evaluating and improving real-world evidence with Targeted Learning.
Gruber S; Phillips RV; Lee H; Concato J; van der Laan M
BMC Med Res Methodol; 2023 Aug; 23(1):178. PubMed ID: 37533017
[TBL] [Abstract][Full Text] [Related]
8. PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCE.
Oehrlein EM; Graff JS; Perfetto EM; Mullins CD; Dubois RW; Anyanwu C; Onukwugha E
Int J Technol Assess Health Care; 2018 Jan; 34(1):111-119. PubMed ID: 29415784
[TBL] [Abstract][Full Text] [Related]
9. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
Klonoff DC
J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738
[TBL] [Abstract][Full Text] [Related]
10. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
11. Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.
Schneeweiss S; Patorno E
Endocr Rev; 2021 Sep; 42(5):658-690. PubMed ID: 33710268
[TBL] [Abstract][Full Text] [Related]
12. Translational hurdles with cannabis medicines.
Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
[TBL] [Abstract][Full Text] [Related]
13. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
[TBL] [Abstract][Full Text] [Related]
14. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
[TBL] [Abstract][Full Text] [Related]
15. Toward a better understanding about real-world evidence.
Liu M; Qi Y; Wang W; Sun X
Eur J Hosp Pharm; 2022 Jan; 29(1):8-11. PubMed ID: 34857642
[TBL] [Abstract][Full Text] [Related]
16. When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
Franklin JM; Platt R; Dreyer NA; London AJ; Simon GE; Watanabe JH; Horberg M; Hernandez A; Califf RM
Clin Pharmacol Ther; 2022 Jan; 111(1):108-115. PubMed ID: 33826756
[TBL] [Abstract][Full Text] [Related]
17. Examining the Use of Real-World Evidence in the Regulatory Process.
Beaulieu-Jones BK; Finlayson SG; Yuan W; Altman RB; Kohane IS; Prasad V; Yu KH
Clin Pharmacol Ther; 2020 Apr; 107(4):843-852. PubMed ID: 31562770
[TBL] [Abstract][Full Text] [Related]
18. Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal.
Makady A; Stegenga H; Ciaglia A; Debray TP; Lees M; Happich M; Ryll B; Abrams K; Thwaites R; Garner S; Jonsson P; Goettsch W
J Comp Eff Res; 2017 Sep; 6(6):485-490. PubMed ID: 28857631
[TBL] [Abstract][Full Text] [Related]
19. Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes.
Patorno E; Schneeweiss S; Wang SV
Diabetes Obes Metab; 2020 Apr; 22 Suppl 3(Suppl 3):45-59. PubMed ID: 32250527
[TBL] [Abstract][Full Text] [Related]
20. Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018-2019.
Eskola SM; Leufkens HGM; Bate A; De Bruin ML; Gardarsdottir H
Clin Pharmacol Ther; 2022 Jan; 111(1):310-320. PubMed ID: 34689334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
